Visit other SMART + STRONG sites:
POZREAL HEALTHTU SALUD
Subscribe to:
E-newsletters
POZ magazine
POZ Personals
Sign In / Join
Username:
Password:

Back to home » Treatment News » Top Stories

Most Popular Stories
Life Expectancy With HIV Increases Dramatically
New Hope for HIV Eradication
New Synthetic Proteins Block HIV
Additional Funding Awarded for Adherence Breathalyzer
A New Avenue Opens for Treating KS, CMV and Other Herpes Diseases
New Life for Treatment Interruptions?
What's That Mean?
(just double-click it!)

If you don't understand one of the words in this article, just double-click it. A window will open with a definition from mondofacto's On-line Medical Dictionary. If the double-click feature doesn't work in your browser, you can enter the word below:

Most Popular Lessons
The HIV Life Cycle
Shingles
Herpes Simplex Virus
Syphilis & Neurosyphilis
Treatments for Opportunistic Infections (OIs)
What is AIDS & HIV?
More News

Have medical or treatment news about HIV? Send press releases, news tips and other announcements to editors@aidsmeds.com.

Click here for more news


emailrssprint

December 7, 2007

Tesamorelin KO’s Belly Fat

Treatment with the synthetic human growth hormone-releasing factor, tesamorelin, resulted in a significant loss of visceral adipose tissue—deep belly fat—compared with a placebo in people with lipodystrophy, according to a new article published in the December 6 issue of the New England Journal of Medicine (NEJM).

The tesamorelin study is a 52-week trial involving 412 patients with lipodystrophy. During the first 26 weeks, 273 patients received tesamorelin and 137 received a placebo. During the second 26 weeks of the study, those who’d originally received placebo switched to tesamorelin, while those who originally received tesamorelin either stayed on the drug or were switched to placebo.

In the NEJM article, Julian Falutz, MD, of the Montreal General Hospital at the McGill University Health Centre, and his colleagues report the results from the first 26 weeks of the study. At week 26, those who’d received tesamorelin had a 15.2 percent decrease in visceral adipose tissue, compared with a 5 percent increase in those who received a placebo. Moreover, people in the tesamorelin group had greater improvements in cholesterol and insulin function than those who received a placebo.

There was no difference in the incidence of serious side effects between those receiving tesamorelin or placebo. However, those taking tesamorelin were more likely to discontinue the drug due to side effects than those in the placebo group.

Preliminary data from the second half of the study were reported at the 2007 European AIDS Conference in Madrid. Final results from the 52-week study have not yet been published in a peer-reviewed medical journal.


Scroll down to comment on this story.

emailrssprint

Name:

(will display; 2-50 characters)

Email:

(will NOT display)

City:

(will display; optional)

Comment (500 characters left):

(Note: The AIDSmeds team review all comments before they are posted. Please do not include ":" "@" "<" ">" in your comment. The opinions expressed by people providing comments are theirs alone. They do not necessarily reflect the opinions of Smart + Strong, which is not responsible for the accuracy of any of the information supplied by people providing comments.)

| Posting Rules

Previous Comments:

comments 1 - 15 (of 21 total)     next > >>

Kellie, Lawrenceville Georgia, 2009-09-01 16:31:46
Would love to know information about this. I am tried of people askin me when is the baby due. Or is it a boy or girl. I would jump in a heartbeat to be able to get rid of this ....

Mark Hooker, Milwaukee, 2008-06-17 18:51:03
Please keep me informed about this new med.

ELFRIEDE ORTEGA, spring, tx., 2008-02-21 11:17:03
my life is very affected for the visceral fat of my belly.

Marc Gold, Austin, 2008-01-22 00:30:41
My quality of life has been tremendously affected by lipo....I would take the risk to try anything

Jim Schumacher, , 2007-12-26 13:21:52
I participated in this study and am anxoiusly awaiting the approval of tesamorlin. Any guess when this may happen.

steve, minnesota, 2007-12-17 18:02:28
There is a currenty recruting trial, study # NCT00435136 at clinicaltrials.gov for a list of the 63 centers that are participating

Ray VEra, , 2007-12-16 22:54:35
PLese keep me inform about this new drug tesamorelin,thanks.

Charlie Baltz, Honolulu, 2007-12-16 09:27:01
Regarding Andrew Werner's inquiries about "insurance reimbursement", I know in some cases it is difficult to breath w/too much belly fat from lipodystrophy;therefore, I would see it as "therapeutical" as long as you inform your physician you are experiencing breathing difficulties. I would also be interested in test trials of this drug in the U.S.

luv, NY, 2007-12-15 17:59:51
Speaking for myself, I would give anything to rid tis lipo; if people stopped because of the side effects then those affects must be pretty bad. What are the side-effects?

Dutchie, Providence/Boston, 2007-12-13 22:12:37
I'd liek to participate in a study in either Providence or Boston. Too bad they couldn't take the belly fat and put it where my behind used to be.

Stuart, Palm Beach, Fl, 2007-12-13 11:27:29
I did contact the pharm. Mfg. today in China to find out about clinical trials in the United States. If they do get back to me, I will post their response!

Stuart, Palm Beach, Fl, 2007-12-13 11:09:48
If anyone does turn up any information please feel free to share it with me. My email address is FRSCatComcast.net I can't seem to find any info either!

Ron, st louis MO, 2007-12-13 00:38:20
where can I get in a belly fat trial ? I jumped to 300 pounds all in the tummy (Lipo) HELP !

Michael, Indianapolis, 2007-12-12 21:16:49
I would like to know where I might be able to enroll in a trial. I've tried a Google search with no success. I live in Indianapolis, IN.

PARKER, Los Angeles, 2007-12-12 16:11:33
Yeah, I'm wondering the same thing as to study details. Does anyone have any perinent infrmation?

comments 1 - 15 (of 21 total)     next > >>


[Go to top]

Quick Links
AIDSmeds en Español
About HIV and AIDS
Lab Tests
My Cool Tools
HIV Meds
Starting Treatment
Switching Treatment
Drug Resistance
Side Effects
Disclosure
Lipodystrophy
Hepatitis & HIV
Women & Children
Fact Sheets
Treatment News
Community Forums
Blogs
Conference Coverage
Health Services Directory
POZ Magazine
Conference Coverage

CROI 2009
Montréal, Canada
February 8-11, 2009


48th Annual ICAAC/IDSA 46th Annual Meeting
Washington, DC
October 25-28, 2008


XVII International AIDS Conference
Mexico City, Mexico
August 3-8, 2008


more conference coverage


[ about AIDSmeds | AIDSmeds advisory board | our staff | advertising policy | advertise/contact us]
© 2009 Smart + Strong. All Rights Reserved. Terms of use and Your privacy